The Latest: Joint venture aims to make 1B doses for Chinese
A Chinese pharmaceutical company and BioNTech SE, the co-developer of the Pfizer-BioNTech vaccine, are setting up a joint venture in China with the capacity to manufacture up to 1 billion doses of the shot to protect against COVID-19 By The Associated Press May 10, 2021, 6:42 AM • 4 min read Share to FacebookShare to… Read More »